SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending after NVIDIA announced a $2 billion investment to expand AI factory capacity and strengthen their strategic partnership. This move is widely seen by the community as a significant validation of CoreWeave's position in the AI infrastructure buildout and a catalyst for massive GPU-centric data capacity expansion. However, some discussions revolve around the investment's specifics and its implications for CoreWeave's financial structure amid broader conversations about the AI compute sector.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is a top trend after securing significant funding from the U.S. government, aiming to bolster a domestic rare earth supply chain crucial for national security. The community is buzzing with optimism, anticipating a substantial surge and a potential short squeeze, though some caution about valuation and potential market pullbacks. This development is viewed as a pivotal move to reduce reliance on foreign sources for critical minerals.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. is experiencing a significant surge, driven by news of a strategic AI licensing deal and substantial preferred equity injection with Valio Technologies in Africa. The market is intensely focused on its extremely low float and high short interest, leading to widespread speculation of a massive short squeeze. This has ignited a lively debate within the community, with many predicting substantial upside while others caution about the stock's extreme volatility.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending following the release of positive three-year functional results from its EMBARK Phase 3 study for Elevidys, its gene therapy for Duchenne muscular dystrophy, demonstrating significant and durable slowing of disease progression. This data has ignited strong community debate, with many investors anticipating a substantial short squeeze and a re-rating of the "undervalued" stock, while others remain cautious given historical market reactions and perceived manipulation. The discussions underscore the importance of long-term efficacy in rare disease treatments and Sarepta's ongoing efforts to solidify its market position despite broader biotech skepticism.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending following its significant acquisition of SkyWater Technology, a strategic move aiming to create a vertically integrated quantum computing powerhouse with in-house chip manufacturing. This development, coupled with major quantum networking projects for the U.S. Air Force, has sparked intense community debate, with many viewing it as a pivotal step toward becoming the 'NVIDIA of Quantum Computing' while others express concerns about potential dilution and valuation.

Skywater Technology, Inc. is a holding company. It engages in the provision of semiconductor development, manufacturing services, and packaging services. The company was founded on October 3, 2016 and is headquartered in Bloomington, MN.

SkyWater Technology Inc

SkyWater Technology is currently trending due to the announced acquisition by IonQ for approximately $1.8 billion, with shares valued at $35 in a cash-and-stock deal. While the offer includes a notable premium, community sentiment is mixed, with many shareholders expressing strong disappointment and viewing the valuation as too low, even considering voting against the deal. This strategic move aims to forge the first vertically integrated quantum computing platform, blending IonQ's quantum technology with SkyWater's domestic semiconductor manufacturing capabilities.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending as investors react to the appointment of an OpenAI expert to its board of directors, signaling a strategic push into advanced AI and quantum-class computing. Community chatter highlights its low float and inclusion on short-squeeze lists, fueling speculative interest and comparisons to recent market runners in anticipation of a significant move.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is drawing significant attention as a multichain meme coin, actively discussed for its presence across Solana, BNB, Cronos, and Base chains via Layerzero technology. The community is buzzing about its deflationary burn mechanism and organic, decentralized nature, touting it as a unique contender in the crypto space.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony (UAMY) is trending as a critical domestic supplier of antimony, essential for national security, driving investor speculation around significant government investment and contracts. The community is highly bullish, emphasizing its integrated supply chain and existing $245 million government contract. Recent share acquisitions by the State of Alaska further fuel excitement in the burgeoning critical minerals sector, with many anticipating substantial price appreciation and potential short squeezes.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

Cel-Sci Corp

CEL-SCI is a top trending topic driven by discussions surrounding recent insider share purchases by its CEO, igniting hope among some for an imminent Breakthrough Medicine Designation from the Saudi FDA for Multikine. This optimism is vigorously debated, however, with skeptics pointing to a history of shareholder dilution and past trial outcomes, intensifying the conversation around the extended regulatory timeline and future funding for its upcoming US confirmatory study.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Q4 Earnings Approaching: Sector ETFs Under Pressure 

Q4 earnings are near for some sectors facing pressure. Autos, Transportation and Staples ETFs CARZ, IYT, XLP look vulnerable.

<ul class="summary-bullets"><li>The airline operator stated that its fourth-quarter (Q4) revenue growth was affected by the government shutdown.&nbsp;</li><li>Delta projects 2026 earnings per share growth of 20% YoY to between $6.50 and $7.50.&nbsp;</li><li>Delta sees first-quarter 2026 total revenue growth of 5-7% and earnings per share between $0.50 and $0.90.</li></ul>Delta Air Lines (DAL) stock tumbled over 6% on Tuesday after a&nbsp;disappointing 2026 profit guidance that overshadowed a slight beat in its fourth-quarter earnings.The airline operator also stated that its fourth-quarter (Q4) revenue growth was affected by the government shutdown as&nbsp;the U.S. aviation regulator ordered a 10% reduction in air traffic to reduce pressure and ensure safety.<h2 class="st-heading-2">Financial Performance And Outlook</h2>In the fourth-quarter, Delta recorded $16.0 billion in operating revenue and earnings per share (EPS) of $1.86. Both revenue and EPS exceeded the analysts’ consensus estimate of $15.7 billion and $1.71, respectively, according to Fiscal AI data.&nbsp;The company said Q4 revenue grew 1.2% year-over-year (YoY) despite a temporary government shutdown impacting domestic operations. Delta projected a 2026 earnings per share growth of 20% YoY to between $6.50 and $7.50.&nbsp;Delta sees first-quarter 2026 total revenue growth of 5-7% and earnings per share between $0.50 and $0.90."2026 is off to a strong start with top-line growth accelerating on consumer and corporate demand. For the full year, we expect to deliver margin expansion and earnings growth of 20 percent year-over-year."-Ed Bastian, CEO, Delta Air Lines<h2 class="st-heading-2">Fleet Expansion&nbsp;</h2>Additionally, Delta announced that it has reached an agreement with Boeing (BA) to acquire 30 787-10 widebody aircraft, with options for an additional 30 planes.Deliveries are expected to start in 2031. The new aircraft promises improved fuel efficiency, cost advantages, and extended long-haul capabilities.&nbsp;"Delta is building the fleet for the future, enhancing the customer experience, driving operational improvements and providing steady replacements for less efficient, older aircraft in the decade to come," added Ed Bastian.&nbsp;Commenting on the deal, CNBC’s Jim Cramer said in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/jimcramer/status/2011039345009140019">post</a> on X that Delta’s large aircraft order represents a major win with high profit potential.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_13_072344_png_7883f7e022.webp" alt="Screenshot 2026-01-13 072344.png" width="595" height="227"></figure><h2 class="st-heading-2">What’s The Retail Mood On Stocktwits?</h2>On Stocktwits, retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/DAL">Delta stock</a> changed to ‘extremely bullish’ from ‘bullish’ territory the previous day. Message volume also shifted to ‘extremely high’ from ‘high’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_13_073843_png_6882a4eb3e.webp" alt="DAL’s Sentiment Meter and Message Volume as of 07:40 a.m. ET on Jan. 13, 2026 | Source: Stocktwits" width="932" height="99"><figcaption>DAL’s Sentiment Meter and Message Volume as of 07:40 a.m. ET on Jan. 13, 2026 | Source: Stocktwits</figcaption></figure>DAL stock has gained over 9% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/what-is-driving-intel-latest-rally-a-fresh-bull-case-from-key-banc/cmUX5XvR44F">What’s Driving Intel’s Latest Rally? A Fresh Bull Case From KeyBanc</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A Delta Airlines plane sits on the tarmac at the Austin-Bergstrom International Airport.

Delta Air Lines Stock Tumbles Despite Q4 Earnings Beat – Even A Boeing Order Failed To Lift Confidence 

In the fourth-quarter, Delta recorded $16.0 billion in operating revenue and earnings per share (EPS) of $1.86, both exceeding analysts’ consensus estimates. 

DAL Stock Tumbles Pre-Market Despite Q4 Beat, Boeing Order: What Spooked Investors?

Equity

In the fourth-quarter, Delta recorded $16.0 billion in operating revenue and earnings per share (EPS) of $1.86, both exceeding analysts’ consensus estimates. 


Should You Invest in the iShares U.S. Transportation ETF (IYT)?

Transportation ETFs Move Into Top Gear With AI in the Driving Seat

Transportation ETFs like HAIL capture attention as AI-driven logistics, automation and smart mobility fuel a stronger run for the transportation sector. 

CSX Corp. (CSX) shares climbed 2.25% in Thursday’s extended trading after the rail-based freight transportation company reported a third-quarter earnings beat, sending retail sentiment soaring.Jacksonville, Florida-based CSX reported adjusted earnings per share (EPS) of $0.44, exceeding the Fiscal.ai-compiled consensus by a penny.&nbsp;CEO Steve Angel said, “This quarter’s operational performance reflects the dedication of our workforce and our commitment to running the best railroad in North America.” “Looking ahead, CSX is well-positioned to build on this momentum to deliver long-term profitable growth and create value for our shareholders.” The third-quarter print marked the first quarterly report under Angel, who assumed reins in late September.Revenue fell 1% year-over-year (Y-o-Y) to $3.587 billion, aligning with the consensus estimate, despite a 1% increase in volume. Lower export coal prices and volume decline in merchandise partially offset the higher other revenue, higher merchandise pricing and intermodal volume growth.Transportation sector peer J.B. Hunt Transportation (JBHT), which competes and partners with CSX in the intermodal freight market, announced <a href="https://stocktwits.com/news-articles/markets/equity/why-did-jb-hunt-stock-pop-over-12-after-hours/ch6YY5UR3Vf">forecast-beating results</a> late Wednesday,&nbsp; inviting a raft of upward price target adjustments by Wall Street analysts. Its stock rallied over 22% in Thursday’s session.Retail Relishes Q3 PrintOn Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/CSX">CSX stock</a> turned ‘extremely bullish’ as of late Thursday from ‘bullish’ the day before. The message volume on the stream increased notably to ‘high’ levels. Retail chatter rose 900% in the 24 hours leading up to late Thursday.A bullish watcher braced for a JBHT-like stock move for CSX on Friday. The user predicted a $40 price for the stock, which ended Thursday’s session down 0.69% at $35.99.<stembedurl>https://stocktwits.com/Dieseld28/message/632675152</stembedurl><stembedurl>https://stocktwits.com/Dieseld28/message/632648786</stembedurl>CSX Stock Outperforms&nbsp;CSX stock has gained 13% this year, outperforming the&nbsp;<a href="https://stocktwits.com/symbol/IYT">iShares Transportation Average (IYT),</a> which is up a more modest 5.8%. According to Koyfin, the average analysts’ price target for CSX is $38.60, implying over 7% upside from Thursday’s close.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/meta-close-to-securing-30-billion-for-louisiana-ai-data-center/ch6rH7dR3FJ">Meta Stock In Focus: Social Media Giant Reportedly Eyes $30B Mega Financing Deal To Power Massive Louisiana AI Data Center</a>

 A CSX locomotive is seen in Orlando. A pay dispute between rail workers and unions threatens a nationwide freight rail strike as early as September 16, 2022. 

Why CSX Stock Rose Over 2% In After-Hours Trading 

Third-quarter revenue fell 1% year-over-year (Y-o-Y) to $3.587 billion, aligning with the consensus estimate, despite a 1% increase in volume.

Q3 Earnings Approaching: Sector ETFs to Win/Lose

Q3 earnings season kicks off with PEP and DAL -- sector ETFs like ITA, XLK, and XLF may gain, while CARZ, PKB and IYT could lag.

ETFs in Focus as Uber Beats on Both Lines

UBER posts strong Q2 with $12.6B revenue and 180M users, while doubling down on robotaxis via Waymo partnership. Play the news with ETF IYT. 

ETFs That Stand to Benefit From the Historic UNP-NSC Merger

UNP's $85B buyout of NSC could lift ETFs like IYT, SUPL, HWAY and FTXR - each with notable stakes in the merging rail giants.

FedEx Shares Slip After Fiscal Q4 Earnings: ETFs in Focus

FDX tops Q4 estimates but falls over 5% on weak guidance, shaking ETFs with high FedEx exposure like SUPL and IYT.


Should You Invest in the U.S. Global Jets ETF (JETS)?

BlackRock Institutional Trust Company N.A. - iShares U.S. Transportation ETF

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

IYT
BlackRock Institutional Trust Company N.A. - iShares U.S. Transportation ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest IYT News

IYTBlackRock Institutional Trust Company N.A. - iShares U.S. Transportation ETF